Published in PLoS One on February 28, 2013
Neuroprotection by astrocytes in brain ischemia: importance of microRNAs. Neurosci Lett (2013) 0.94
The two-hit hypothesis for neuroinflammation: role of exogenous ATP in modulating inflammation in the brain. Front Cell Neurosci (2014) 0.86
Microglia trigger astrocyte-mediated neuroprotection via purinergic gliotransmission. Sci Rep (2014) 0.85
Methylmercury impairs canonical dopamine metabolism in rat undifferentiated pheochromocytoma (PC12) cells by indirect inhibition of aldehyde dehydrogenase. Toxicol Sci (2015) 0.78
Differential effects of P2Y1 deletion on glial activation and survival of photoreceptors and amacrine cells in the ischemic mouse retina. Cell Death Dis (2014) 0.77
Methylmercury induces the expression of TNF-α selectively in the brain of mice. Sci Rep (2016) 0.75
Oral Delivery of a Synthetic Sterol Reduces Axonopathy and Inflammation in a Rodent Model of Glaucoma. Front Neurosci (2017) 0.75
Cell-permeable p38 MAP kinase promotes migration of adult neural stem/progenitor cells. Sci Rep (2016) 0.75
Metal Ion Toxins and Brain Aquaporin-4 Expression: An Overview. Front Neurosci (2016) 0.75
Advances in astrocyte-targeted approaches for stroke therapy: an emerging role for mitochondria and microRNAS. Neurochem Res (2014) 0.75
PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem (1995) 14.14
SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci U S A (2001) 11.06
The toxicology of mercury--current exposures and clinical manifestations. N Engl J Med (2003) 6.95
Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25. Nature (1993) 5.73
GLIA: listening and talking to the synapse. Nat Rev Neurosci (2001) 4.67
Pannexin 1 in erythrocytes: function without a gap. Proc Natl Acad Sci U S A (2006) 4.03
Pharmacological properties of homomeric and heteromeric pannexin hemichannels expressed in Xenopus oocytes. J Neurochem (2005) 3.87
P2X7 receptors mediate ATP release and amplification of astrocytic intercellular Ca2+ signaling. J Neurosci (2006) 3.14
ATP released by astrocytes mediates glutamatergic activity-dependent heterosynaptic suppression. Neuron (2003) 3.05
The toxicology of mercury. Crit Rev Clin Lab Sci (1997) 2.97
Proteolysis of SNAP-25 by types E and A botulinal neurotoxins. J Biol Chem (1994) 2.59
Identification of mitogen-activated protein (MAP) kinase-activated protein kinase-3, a novel substrate of CSBP p38 MAP kinase. J Biol Chem (1996) 2.55
Identification of a vesicular nucleotide transporter. Proc Natl Acad Sci U S A (2008) 2.53
Connexin 43 hemichannels are permeable to ATP. J Neurosci (2008) 2.46
Regulated ATP release from astrocytes through lysosome exocytosis. Nat Cell Biol (2007) 2.38
Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y(1) receptor-null mice. J Clin Invest (1999) 2.34
Intercellular calcium signaling mediated by point-source burst release of ATP. Proc Natl Acad Sci U S A (2002) 2.08
Kinetics of TNF, IL-6, and IL-8 gene expression in LPS-stimulated human whole blood. Biochem Biophys Res Commun (1991) 1.86
Endogenous nonneuronal modulators of synaptic transmission control cortical slow oscillations in vivo. Proc Natl Acad Sci U S A (2009) 1.76
Vesicular release of ATP at central synapses. Pflugers Arch (2006) 1.69
Cerebral interleukin-6 is neuroprotective during permanent focal cerebral ischemia in the rat. J Cereb Blood Flow Metab (1998) 1.63
Human P2Y1 receptor: molecular modeling and site-directed mutagenesis as tools to identify agonist and antagonist recognition sites. J Med Chem (1998) 1.61
Ambivalent aspects of interleukin-6 in cerebral ischemia: inflammatory versus neurotrophic aspects. J Cereb Blood Flow Metab (2008) 1.59
ATP excites interneurons and astrocytes to increase synaptic inhibition in neuronal networks. J Neurosci (2004) 1.57
Dynamic inhibition of excitatory synaptic transmission by astrocyte-derived ATP in hippocampal cultures. Proc Natl Acad Sci U S A (2003) 1.55
Accelerated Nerve Regeneration in Mice by upregulated expression of interleukin (IL) 6 and IL-6 receptor after trauma. J Exp Med (1996) 1.47
Inflammatory cytokines IL-1 alpha, IL-1 beta, IL-6, and TNF-alpha impart neuroprotection to an excitotoxin through distinct pathways. J Immunol (1999) 1.45
Vesicular ATP is the predominant cause of intercellular calcium waves in astrocytes. J Gen Physiol (2007) 1.43
Hydrogen peroxide alters membrane and cytoskeleton properties and increases intercellular connections in astrocytes. J Cell Sci (2005) 1.43
P2X7-like receptor activation in astrocytes increases chemokine monocyte chemoattractant protein-1 expression via mitogen-activated protein kinase. J Neurosci (2001) 1.38
Reactive oxygen species formation as a biomarker of methylmercury and trimethyltin neurotoxicity. Neurotoxicology (1992) 1.38
An analysis of autopsy brain tissue from infants prenatally exposed to methymercury. Neurotoxicology (1995) 1.35
IL-17 enhancement of the IL-6 signaling cascade in astrocytes. J Immunol (2010) 1.22
ICAM-1-induced expression of proinflammatory cytokines in astrocytes: involvement of extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways. J Immunol (2000) 1.21
Oxidative stress in neurotoxic effects of methylmercury poisoning. Neurotoxicology (1996) 1.21
Maxi-anion channel as a candidate pathway for osmosensitive ATP release from mouse astrocytes in primary culture. Cell Res (2008) 1.20
Upregulation of the enzyme chain hydrolyzing extracellular ATP after transient forebrain ischemia in the rat. J Neurosci (1998) 1.19
Mechanisms of methylmercury-induced neurotoxicity: evidence from experimental studies. Life Sci (2011) 1.16
Methylmercury-induced neurotoxicity and apoptosis. Chem Biol Interact (2010) 1.13
Impaired inflammatory response and increased oxidative stress and neurodegeneration after brain injury in interleukin-6-deficient mice. Glia (2000) 1.09
Purinergic transmission in the central nervous system. Pflugers Arch (2006) 1.09
Differential properties of astrocyte calcium waves mediated by P2Y1 and P2Y2 receptors. J Neurosci (2003) 1.08
Mechanisms of prostaglandin E2-induced interleukin-6 release in astrocytes: possible involvement of EP4-like receptors, p38 mitogen-activated protein kinase and protein kinase C. J Neurochem (2001) 1.07
Purinergic signaling induces thrombospondin-1 expression in astrocytes. Proc Natl Acad Sci U S A (2006) 1.07
Palmitate induced IL-6 and MCP-1 expression in human bladder smooth muscle cells provides a link between diabetes and urinary tract infections. PLoS One (2010) 1.06
Role of mitogen-activated protein kinases in inducible nitric oxide synthase and TNFalpha expression in human fetal astrocytes. J Neuroimmunol (2002) 1.02
P2Y1 receptor signaling enhances neuroprotection by astrocytes against oxidative stress via IL-6 release in hippocampal cultures. Glia (2009) 1.01
Inhibition by ATP of calcium oscillations in rat cultured hippocampal neurones. Br J Pharmacol (1997) 0.95
Antioxidant compounds and Ca(2+) pathway blockers differentially protect against methylmercury and mercuric chloride neurotoxicity. J Neurosci Res (2001) 0.94
Oncostatin M regulation of interleukin-6 expression in astrocytes: biphasic regulation involving the mitogen-activated protein kinases ERK1/2 and p38. J Neurochem (2000) 0.94
Post-transcriptional stabilization by interleukin-1beta of interleukin-6 mRNA induced by c-kit ligand and interleukin-10 in mouse bone marrow-derived mast cells. J Biol Chem (1996) 0.94
Comparative study on the response of rat primary astrocytes and microglia to methylmercury toxicity. Glia (2011) 0.93
Methylmercury toxicity and Nrf2-dependent detoxification in astrocytes. Toxicol Sci (2008) 0.92
Interleukin-6 protects cultured cerebellar granule neurons against glutamate-induced neurotoxicity. Neurosci Lett (2004) 0.92
Cytoprotection against oxidative stress-induced damage of astrocytes by extracellular ATP via P2Y1 receptors. Glia (2005) 0.92
Monocytes infected with Mycobacterium tuberculosis regulate MAP kinase-dependent astrocyte MMP-9 secretion. J Leukoc Biol (2006) 0.91
Methylmercury causes glial IL-6 release. Neurosci Lett (2007) 0.91
Interleukin-6 upregulates neuronal adenosine A1 receptors: implications for neuromodulation and neuroprotection. Neuropsychopharmacology (2007) 0.90
The consequences of methylmercury exposure on interactive functions between astrocytes and neurons. Neurotoxicology (2002) 0.89
Interleukin-6 enhances expression of adenosine A(1) receptor mRNA and signaling in cultured rat cortical astrocytes and brain slices. Neuropsychopharmacology (2001) 0.87
Sensitivity of immature neurons in culture to metal-induced changes in reactive oxygen species and intracellular free calcium. Neurotoxicology (2000) 0.87
Thromboxane A2 promotes interleukin-6 biosynthesis mediated by an activation of cyclic AMP-response element-binding protein in 1321N1 human astrocytoma cells. Mol Pharmacol (2005) 0.86
Grape seed extract acting on astrocytes reveals neuronal protection against oxidative stress via interleukin-6-mediated mechanisms. Cell Mol Neurobiol (2009) 0.85
Astrocytes as modulators of mercury-induced neurotoxicity. Neurotoxicology (1997) 0.83
Extracellular ATP counteracts the ERK1/2-mediated death-promoting signaling cascades in astrocytes. Glia (2006) 0.81
Hemin inhibits NO production by IL-1β-stimulated human astrocytes through induction of heme oxygenase-1 and reduction of p38 MAPK activation. J Neuroinflammation (2010) 0.80
Methylmercury: a potential environmental risk factor contributing to epileptogenesis. Neurotoxicology (2011) 0.79
IL-6 release from mouse glia caused by MeHg requires cytosolic phospholipase A2 activation. Neurosci Lett (2009) 0.79
Astrocytic swelling, phospholipase A2, glutathione and glutamate: interactions in methylmercury-induced neurotoxicity. Cell Mol Biol (Noisy-le-grand) (2000) 0.79
Possible involvement of catalase in the protective effect of interleukin-6 against 6-hydroxydopamine toxicity in PC12 cells. Brain Res Bull (1997) 0.79
Methylmercury-induced IL-6 release requires phospholipase C activities. Neurosci Lett (2011) 0.78
P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature (2003) 6.04
International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol Rev (2006) 5.28
Platelet-derived serotonin mediates liver regeneration. Science (2006) 2.98
Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate. J Am Coll Cardiol (2010) 2.55
Characterization of the UDP-glucose receptor (re-named here the P2Y14 receptor) adds diversity to the P2Y receptor family. Trends Pharmacol Sci (2003) 2.37
Possible involvement of P2Y2 metabotropic receptors in ATP-induced transient receptor potential vanilloid receptor 1-mediated thermal hypersensitivity. J Neurosci (2003) 1.69
Megakaryocytes assemble podosomes that degrade matrix and protrude through basement membrane. Blood (2013) 1.65
Cardiovascular mortality in chronic kidney disease patients undergoing percutaneous coronary intervention is mainly related to impaired P2Y12 inhibition by clopidogrel. J Am Coll Cardiol (2011) 1.64
The TRPV4 cation channel mediates stretch-evoked Ca2+ influx and ATP release in primary urothelial cell cultures. J Biol Chem (2009) 1.61
Microparticles are new biomarkers of septic shock-induced disseminated intravascular coagulopathy. Intensive Care Med (2013) 1.56
A role of the fast ATP-gated P2X1 cation channel in thrombosis of small arteries in vivo. J Exp Med (2003) 1.56
Dynamic inhibition of excitatory synaptic transmission by astrocyte-derived ATP in hippocampal cultures. Proc Natl Acad Sci U S A (2003) 1.55
Defective tubulin organization and proplatelet formation in murine megakaryocytes lacking Rac1 and Cdc42. Blood (2013) 1.52
MRS2500 [2-iodo-N6-methyl-(N)-methanocarba-2'-deoxyadenosine-3',5'-bisphosphate], a potent, selective, and stable antagonist of the platelet P2Y1 receptor with strong antithrombotic activity in mice. J Pharmacol Exp Ther (2005) 1.51
Biogenesis of the demarcation membrane system (DMS) in megakaryocytes. Blood (2013) 1.47
Romiplostim administration shows reduced megakaryocyte response-capacity and increased myelofibrosis in a mouse model of MYH9-RD. Blood (2012) 1.45
Impact of P2Y12 inhibition by clopidogrel on cardiovascular mortality in unselected patients treated by percutaneous coronary angioplasty: a prospective registry. JACC Cardiovasc Interv (2010) 1.42
Ca2+ waves in keratinocytes are transmitted to sensory neurons: the involvement of extracellular ATP and P2Y2 receptor activation. Biochem J (2004) 1.42
Extracellular nucleotide signaling in adult neural stem cells: synergism with growth factor-mediated cellular proliferation. Development (2006) 1.41
Megakaryocyte-restricted MYH9 inactivation dramatically affects hemostasis while preserving platelet aggregation and secretion. Blood (2007) 1.29
Signaling role for phospholipase C gamma 2 in platelet glycoprotein Ib alpha calcium flux and cytoskeletal reorganization. Involvement of a pathway distinct from FcR gamma chain and Fc gamma RIIA. J Biol Chem (2003) 1.24
Preparation of washed platelet suspensions from human and rodent blood. Methods Mol Biol (2004) 1.23
RUNX1-induced silencing of non-muscle myosin heavy chain IIB contributes to megakaryocyte polyploidization. Nat Commun (2012) 1.22
Functional vanilloid receptors in cultured normal human epidermal keratinocytes. Biochem Biophys Res Commun (2002) 1.20
Importance of platelet phospholipase Cgamma2 signaling in arterial thrombosis as a function of lesion severity. Arterioscler Thromb Vasc Biol (2005) 1.20
Fibronectin/integrin system is involved in P2X(4) receptor upregulation in the spinal cord and neuropathic pain after nerve injury. Glia (2008) 1.17
The P2 receptors in platelet function. Semin Thromb Hemost (2005) 1.17
Involvement of beta1 integrin in microglial chemotaxis and proliferation on fibronectin: different regulations by ADP through PKA. Glia (2005) 1.14
Toward multivalent signaling across G protein-coupled receptors from poly(amidoamine) dendrimers. Bioconjug Chem (2008) 1.13
Podocyte-specific deletion of Myh9 encoding nonmuscle myosin heavy chain 2A predisposes mice to glomerulopathy. Mol Cell Biol (2011) 1.11
G-protein-coupled receptors as signaling targets for antiplatelet therapy. Arterioscler Thromb Vasc Biol (2008) 1.10
Direct voltage control of signaling via P2Y1 and other Galphaq-coupled receptors. J Biol Chem (2004) 1.09
Multiple alterations of platelet functions dominated by increased secretion in mice lacking Cdc42 in platelets. Blood (2010) 1.07
Differential regulation and relocalization of the platelet P2Y receptors after activation: a way to avoid loss of hemostatic properties? Mol Pharmacol (2004) 1.07
Direct observation of ATP-induced conformational changes in single P2X(4) receptors. PLoS Biol (2009) 1.06
Platelet ADP receptors contribute to the initiation of intravascular coagulation. Blood (2003) 1.05
A 2-step mechanism of arterial thrombus formation induced by human atherosclerotic plaques. J Am Coll Cardiol (2010) 1.05
Thyroid hormone targets matrix Gla protein gene associated with vascular smooth muscle calcification. Circ Res (2005) 1.05
Integrin-dependent interaction of lipid rafts with the actin cytoskeleton in activated human platelets. J Cell Sci (2005) 1.05
Deficiency of Src homology 2 domain-containing inositol 5-phosphatase 1 affects platelet responses and thrombus growth. J Clin Invest (2007) 1.04
Abnormal megakaryocyte morphology and proplatelet formation in mice with megakaryocyte-restricted MYH9 inactivation. Blood (2008) 1.04
Identification of a unique co-operative phosphoinositide 3-kinase signaling mechanism regulating integrin alpha IIb beta 3 adhesive function in platelets. J Biol Chem (2007) 1.04
Differential involvement of the P2Y1 and P2Y12 receptors in platelet procoagulant activity. Arterioscler Thromb Vasc Biol (2003) 1.03
Direct excitation of inhibitory interneurons by extracellular ATP mediated by P2Y1 receptors in the hippocampal slice. J Neurosci (2004) 1.03
ATP- and adenosine-mediated signaling in the central nervous system: chronic pain and microglia: involvement of the ATP receptor P2X4. J Pharmacol Sci (2004) 1.03
The role of nucleotides in the neuron--glia communication responsible for the brain functions. J Neurochem (2007) 1.02
Purinoceptors are involved in the induction of an osmolyte permeability in malaria-infected and oxidized human erythrocytes. FASEB J (2005) 1.00
Microglia release ATP by exocytosis. Glia (2013) 1.00
Identification of a novel 14-3-3zeta binding site within the cytoplasmic tail of platelet glycoprotein Ibalpha. Blood (2004) 0.99
P2 receptors and platelet function. Purinergic Signal (2011) 0.98
ADF/n-cofilin-dependent actin turnover determines platelet formation and sizing. Blood (2010) 0.98
Inhibition of platelet functions and thrombosis through selective or nonselective inhibition of the platelet P2 receptors with increasing doses of NF449 [4,4',4'',4'''-(carbonylbis(imino-5,1,3-benzenetriylbis-(carbonylimino)))tetrakis-benzene-1,3-disulfonic acid octasodium salt]. J Pharmacol Exp Ther (2005) 0.97
Neuropsychiatric background of alcohol hallucinosis: a SPECT study. J Neuropsychiatry Clin Neurosci (2007) 0.97
Major contribution of the P2Y₁receptor in purinergic regulation of TNFα-induced vascular inflammation. Circulation (2011) 0.97
Alteration of fractional anisotropy and apparent diffusion coefficient in obsessive-compulsive disorder: a diffusion tensor imaging study. Prog Neuropsychopharmacol Biol Psychiatry (2008) 0.96
PEGylated dendritic unimolecular micelles as versatile carriers for ligands of G protein-coupled receptors. Bioconjug Chem (2009) 0.96
The practice of child and adolescent psychiatry: a survey of early-career psychiatrists in Japan. Child Adolesc Psychiatry Ment Health (2009) 0.95
Reduced atherosclerotic lesions in P2Y1/apolipoprotein E double-knockout mice: the contribution of non-hematopoietic-derived P2Y1 receptors. Circulation (2008) 0.94
The P2Y(1) receptor is involved in the maintenance of glucose homeostasis and in insulin secretion in mice. Purinergic Signal (2005) 0.93
The recently deorphanized GPR80 (GPR99) proposed to be the P2Y15 receptor is not a genuine P2Y receptor. Trends Pharmacol Sci (2005) 0.93
Clopidogrel 150 mg/day to overcome low responsiveness in patients undergoing elective percutaneous coronary intervention: results from the VASP-02 (Vasodilator-Stimulated Phosphoprotein-02) randomized study. JACC Cardiovasc Interv (2008) 0.93
Characterization of multiple P2X receptors in cultured normal human epidermal keratinocytes. J Invest Dermatol (2005) 0.92
Cytoprotection against oxidative stress-induced damage of astrocytes by extracellular ATP via P2Y1 receptors. Glia (2005) 0.92
Cortical astrocytes rewire somatosensory cortical circuits for peripheral neuropathic pain. J Clin Invest (2016) 0.92
Coordinate pathways for nucleotide and EGF signaling in cultured adult neural progenitor cells. J Cell Sci (2009) 0.91
Continuous D-lactic acid production by a novel thermotolerant Lactobacillus delbrueckii subsp. lactis QU 41. Appl Microbiol Biotechnol (2010) 0.91
Nonexploratory movement and behavioral alterations in a thalidomide or valproic acid-induced autism model rat. Neurosci Res (2009) 0.91
A general approach toward the synthesis of C-nucleoside pyrazolo[1,5-a]-1,3,5-triazines and their 3',5'-bisphosphate C-nucleotide analogues as the first reported in vivo stable P2Y(1)-receptor antagonists. J Org Chem (2002) 0.90
The P2Y(1) receptor as a target for new antithrombotic drugs: a review of the P2Y(1) antagonist MRS-2179. Cardiovasc Drug Rev (2003) 0.90
Myosin IIA is critical for organelle distribution and F-actin organization in megakaryocytes and platelets. Blood (2013) 0.90
Intrinsic impaired proplatelet formation and microtubule coil assembly of megakaryocytes in a mouse model of Bernard-Soulier syndrome. Haematologica (2009) 0.89
Quantification of recombinant and platelet P2Y(1) receptors utilizing a [(125)I]-labeled high-affinity antagonist 2-iodo-N(6)-methyl-(N)-methanocarba-2'-deoxyadenosine-3',5'-bisphosphate ([(125)I]MRS2500). Pharmacol Res (2010) 0.89
Regulation of cell-to-cell communication mediated by astrocytic ATP in the CNS. Purinergic Signal (2005) 0.89
Reduced pain behaviors and extracellular signal-related protein kinase activation in primary sensory neurons by peripheral tissue injury in mice lacking platelet-activating factor receptor. J Neurochem (2007) 0.89
In vitro blood-brain barrier models using brain capillary endothelial cells isolated from neonatal and adult rats retain age-related barrier properties. PLoS One (2013) 0.89
Purinergic signaling promotes proliferation of adult mouse subventricular zone cells. J Neurosci (2012) 0.89
The astrocyte-targeted therapy by Bushi for the neuropathic pain in mice. PLoS One (2011) 0.89
Integrin α6β1 is the main receptor for vascular laminins and plays a role in platelet adhesion, activation, and arterial thrombosis. Circulation (2013) 0.88
Isolation and characterisation of lactic acid bacterium for effective fermentation of cellobiose into optically pure homo L-(+)-lactic acid. Appl Microbiol Biotechnol (2011) 0.88
Downregulation of P2X3 receptor-dependent sensory functions in A/J inbred mouse strain. Eur J Neurosci (2002) 0.88
Effect of traditional Japanese herbal medicine toki-shakuyaku-san for mild cognitive impairment: SPECT study. Psychiatry Clin Neurosci (2007) 0.88
Evidence for P2Y1, P2Y2, P2Y6 and atypical UTP-sensitive receptors coupled to rises in intracellular calcium in mouse cultured superior cervical ganglion neurons and glia. Br J Pharmacol (2004) 0.88
Efficient homofermentative L-(+)-lactic acid production from xylose by a novel lactic acid bacterium, Enterococcus mundtii QU 25. Appl Environ Microbiol (2010) 0.87